Tilray: Brand Overview
Tilray began in 2013 and expanded into a global medical cannabis supplier with EU-GMP facilities. Australia is served through pharmacies and health professionals operating under local access frameworks. Supply is professional-channel only. Transparency varies by product line.
Australian consumers interact via clinics and pharmacies rather than direct online purchases from Tilray. The ANZ team supports prescribers and dispensaries with product information and ordering portals. Public-facing technical depth remains limited.
The catalogue spans purified CBD oils with THC non-detect, balanced THC:CBD oils, and medical flower. In 2025, Tilray introduced Good Supply pastilles for the Australian medical channel. Choice depends on preferences rather than promised outcomes.
Company background
EU-GMP sites in Portugal and Germany underpin Tilray’s international supply to regulated markets. Portugal commonly appears as the country of origin on Australian-labelled oils. German capacity supports broader EU distribution and scale.
Tilray Medical ANZ operates from Sydney, engaging healthcare professionals and dispensing pharmacies. The focus is regulated supply rather than brand-led retail. Public batch lookup tools are not advertised.
Positioning & transparency
Tilray positions squarely in the professional medical channel with a broad product matrix. COAs are typically shared through healthcare or pharmacy portals instead of a public database. Consumer-facing technical disclosures are selective.
Public COA access for Australian SKUs remains Not disclosed by brand. Batch-level documentation is usually requested through prescribers or pharmacies. Availability can vary over time.
Tilray: Key Facts
- Founding year: 2013
- HQ country: Canada; EU-GMP production in Portugal and Germany
- AU presence: Active; pharmacy and HCP supply
- Positioning: EU-GMP medical cannabis supplier to professional channels
- THC stance: Offers THC-only, CBD-only (THC non-detect), and balanced THC:CBD lines
- Formats: CBD oils; medical flower; Good Supply pastilles
- Types: Full-spectrum CBD; Isolate CBD; Broad-spectrum CBD Not disclosed by brand
- Strengths & sizes: Examples include CBD25 40 mL; CBD100 25–100 mL; 10:10 40 mL; 25:25 25 mL; 5:20 40 mL
- Extraction: Ethanol mentioned; CO₂ also referenced; AU specifics Not disclosed by brand
- Hemp origin: Portugal frequently listed; finer farm details Not disclosed by brand
- Certifications: EU-GMP
- Carrier/base: MCT oil
- Vegan/allergen notes: Not disclosed by brand
- COA access: Public portal Not disclosed by brand; HCP/pharmacy access noted
- Testing scope: Cannabinoid potency noted; broader contaminants Not disclosed by brand
- ISO 17025 lab: Not disclosed by brand
- Batch testing frequency: Not disclosed by brand
- AU access pathway: Supplied under SAS/AP frameworks
Tilray: Product Range & Who It Suits
The Australian range centres on oral oils, with purified CBD and full-spectrum options at varying strengths. Medical flower appears under Tilray and Redecan for pharmacy dispensing. Pastilles under Good Supply broaden format choice.
Purified CBD oils labelled THC non-detect may appeal to THC-sensitive users seeking CBD-only products. Balanced oils provide non-promotional ratio options in MCT bases with neutral taste. Flower suits users prioritising cultivar variety within approved pathways.
Pastilles offer discrete, pre-portioned units for those preferring measured convenience. Oils remain versatile for gradual titration by prescribers, whereas flower requires inhalation hardware. Suitability depends on lifestyle preferences, not outcomes.
Formats in Australia
Oils use MCT carrier and come in bottle sizes around 25–100 mL. Strengths range from CBD25 to CBD100, alongside balanced THC:CBD ratios. Packaging aims for clarity and consistency.
Pastilles are presented in CBD-dominant and balanced variants in multi-unit packs. They are dispensed via pharmacies on prescription. Flower formats are typically 10–15 g jars.
Who each format suits
Oils suit users wanting neutral flavour, measured administration, and discretion. Pastilles suit those preferring simple counting rather than measuring liquid volumes. Flower suits those prioritising cultivar character and fast onset.
Forms & Types audit (Australia):
- CBD Oils — Available: Purified CBD25 40 mL; CBD100 25–100 mL; full-spectrum 10:10, 5:20, 25:25
- CBD Gummies/Pastilles — Available: Good Supply CBD20, THC10:CBD10, THC10; packs of 60
- CBD Capsules — Not disclosed by brand
- CBD Topicals — Not disclosed by brand
- CBD Vapes — Not disclosed by brand
- CBD Pet products — Not disclosed by brand
- Medical Flower — Available: Tilray and Redecan pharmacy formats
- Full-spectrum CBD — Available
- Isolate CBD — Available
- Broad-spectrum CBD — Not disclosed by brand
Tilray: Quality, Sourcing & Extraction
EU-GMP manufacturing anchors Tilray’s approach to quality and process control. Australian product labels frequently cite Portugal as country of origin for oils. German facilities support supply breadth and resilience.
Extraction references include ethanol for several oral solutions, with CO₂ discussed in educational contexts. AU batch-level extraction detail beyond these mentions is Not disclosed by brand. Consistency is supported by controlled manufacturing environments.
MCT appears as the primary carrier oil across cited lines. Vegan status and allergen declarations remain Not disclosed by brand. THC-removal specifics for purified oils are likewise Not disclosed by brand.
Hemp origin & standards
Portugal features prominently as the manufacturing location for AU-labelled oils. Farm-level provenance and cultivation practices are Not disclosed by brand. EU-GMP indicates stringent manufacturing oversight rather than farming details.
Extraction & refinement
Ethanol extraction is identified on several AU-facing product specifications. CO₂ may apply to select lines outside those listings. Refinement steps beyond THC non-detect statements are Not disclosed by brand.
Tilray: Lab Testing, COAs & Safety
COAs are commonly shared through HCP or pharmacy channels, not via a public AU portal. Patients typically request documents from their prescriber or dispensing pharmacy. Public batch search remains Not disclosed by brand.
AU consumer pages emphasise cannabinoid potency reporting. Broader contaminant panels, lab accreditations, and cyclic batch frequency details are Not disclosed by brand. Safety information is framed within regulated supply norms rather than claims.
COA access
Access occurs through professional portals or on request via pharmacies. Batch-specific lookups for the public are not provided. Documentation practices may vary by product line.
Testing scope & frequency
- Cannabinoids: Potency values disclosed on AU product documents
- Heavy metals: Not disclosed by brand
- Pesticides: Not disclosed by brand
- Residual solvents: Not disclosed by brand
- Microbials: Not disclosed by brand
- ISO 17025 lab: Not disclosed by brand
- Batch frequency: Not disclosed by brand
Tilray: Pricing & Value
Pricing in Australia varies by potency, bottle size, and formulation. Large-format CBD100 carries the highest upfront cost but often a lower per-mg rate. Balanced oils and flower sit near mid-market levels at cited pharmacies.
Pastille pricing is not publicly detailed by the brand at the time of writing. Pharmacies may set retail prices that change over time. Value depends on strength, pack size, and availability.
| Product | Size | Strength | Price (A$) | Approx. Price (US$) |
|---|---|---|---|---|
| Purified CBD100 oil | 100 mL | 100 mg/mL (THC ND) | ~1,000 | ~US$650 |
| Purified CBD100 oil | 25 mL | 100 mg/mL (THC ND) | ~280 | ~US$182 |
| Full-spectrum 25:25 oil | 25 mL | 25 mg/mL THC + 25 mg/mL CBD | 160 | ~US$104 |
| Full-spectrum 10:10 oil | 40 mL | 10 mg/mL THC + 10 mg/mL CBD | 120 | ~US$78 |
| Full-spectrum 5:20 oil | 40 mL | 5 mg/mL THC + 20 mg/mL CBD | 110 | ~US$72 |
| Medical flower (Tilray/Redecan) | 15 g | THC 22% (example) | 160 | ~US$104 |
| Good Supply pastilles CBD20 | 60 units | CBD-dominant | Not disclosed by brand | Not disclosed by brand |
Prices in AUD; USD approximations based on exchange rates as of October 2025.
Price drivers
Potency, format, and bottle size heavily influence effective price per milligram. Transparency and batch documentation can affect perceived value. Promotions and subscriptions are Not disclosed by brand.
Value considerations
Large bottles of CBD100 often yield stronger per-mg economics than smaller sizes. Balanced oils provide mid-tier pricing with ratio flexibility. Flower sits around typical pharmacy price points.
Subscriptions & Bundles
Direct-to-patient subscriptions are not advertised by Tilray in Australia. Recurring discounts, cadence options, and cancellation terms are Not disclosed by brand. Pharmacies may operate their own programs independently.
Bundle offerings at the brand level are Not disclosed by brand. Any savings likely depend on pharmacy policy and stock status. Details may change without notice.
Payments & Checkout in Australia
Payments occur at pharmacies rather than through Tilray’s website. Accepted methods vary, typically including major cards or EFTPOS depending on the pharmacy. Brand-level specifics are Not disclosed by brand.
Support for digital wallets, bank transfers, or crypto at the brand level is Not disclosed by brand. Consumers should confirm with their dispensing pharmacy. Checkout remains pharmacy-managed.
Shipping, Delivery & Returns in Australia
Tilray supplies product to pharmacies within regulated medical distribution channels. Direct consumer shipping policies are Not disclosed by brand. Carriers, fees, and timeframes are not published.
Returns are generally handled by pharmacies according to their policies. Brand-level windows and conditions are Not disclosed by brand. Consumers should check the pharmacy’s terms before purchase.
Shipping timeframes
Public service-level commitments for Australian consumer delivery are Not disclosed by brand. Pharmacies determine dispatch schedules and costs. Availability can influence timing.
Returns policy
Consumer-facing returns guidance from Tilray is Not disclosed by brand. Pharmacies may apply restocking fees for change-of-mind returns. Fault handling follows pharmacy procedures.
Tilray: Reputation & Customer Feedback
Independent directories and pharmacy listings indicate broad availability across oils and flower. Pricing sentiment tends to place Tilray in the mid to high bracket. Perceived value improves with larger bottle formats.
Taste and packaging sentiment ranges from neutral to positive depending on product line. Stock availability can fluctuate, especially for popular flowers. Effects commentary is excluded.
Positive
- EU-GMP provenance and multinational manufacturing footprint
- Range covering purified CBD, balanced oils, flower, and pastilles
- Wide pharmacy network access across Australia
Neutral/mixed
- Pricing perceived as mid to high depending on strength and size
- Occasional stock variability on popular SKUs
Negative
- Public AU COA access limited; batch data via professional channels
- Testing scope, ISO 17025 detail, and batch frequency Not disclosed by brand
- Payments, shipping, and returns policies at consumer level Not disclosed by brand
Pros & Cons
Pros
- EU-GMP manufacturing with Portugal and Germany production
- Diverse formats: purified oils, balanced oils, medical flower, and pastilles
- Clear CBD isolate positioning with THC non-detect labelling
Cons
- No public AU COA library; access routed via HCP/pharmacy
- Key testing and lab accreditation details Not disclosed by brand
- No brand-run subscriptions, payment, or delivery disclosures for consumers
FAQ
Is Tilray available in Australia?
Yes. Tilray supplies pharmacies and health professionals under regulated access pathways. Direct-to-consumer sales are not offered.
Does Tilray offer CBD-only products?
Yes. Purified CBD oils labelled THC non-detect are part of the Australian range.
Are COAs publicly accessible in Australia?
No public AU batch portal is provided. COAs are generally obtained via prescribers or pharmacies.
What product formats are available?
Oils, medical flower, and Good Supply pastilles are available through pharmacies.
Where are Tilray’s Australian oils produced?
Portugal is commonly identified as the country of origin on AU-labelled oils.
Which extraction methods are used?
Ethanol is listed on several AU specifications. Additional processing details are Not disclosed by brand.
What are typical prices in Australia?
Large CBD100 bottles can approach A$1,000, while balanced oils and flower sit mid-range. Pharmacy pricing can vary.
Does Tilray offer subscriptions or bundles?
Brand-run subscriptions and bundles are Not disclosed by brand. Pharmacies may operate independent programs.
Can consumers order directly from Tilray in Australia?
No. Products are accessed via healthcare professionals and supplied by pharmacies.
Which payment methods are accepted?
Payments are handled by pharmacies. Brand-level payment options are Not disclosed by brand.
Conclusion
Tilray operates as an EU-GMP supplier to Australia’s medical channel with oils, flower, and pastilles. The professional distribution model limits direct consumer detail on testing, logistics, and payments. Document access typically occurs through prescribers.
Those prioritising regulated pharmacy access and measured oil formats may find Tilray suitable. Public disclosures leave gaps, with several items marked Not disclosed by brand. Suitability should be assessed against format preferences and budget.
